DSpace at RU >

Search Results

Results 1-50 of 75.

Item hits:

Full Text	Issue Date	Title	Author(s)
	2012	Suppressing antagonistic bioengineering feedbacks doubles restoration success.	Suykerbuyk, W.; Bouma, T.J.; Heide, T. van der; Faust, C.; Govers, L.L.; Giesen, W.B.J.T.; Jong, D.J. de; Katwijk, M.M. van
	2012	Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes	Kleinnijenhuis, J.; Quintin, J.; Preyers, F.W.; Joosten, L.A.B.; Ifrim, D.C.; Saeed, S.; Jacobs, C.; Loenhout, J. van; de Jong, D.J.; Stunnenberg, H.G.; Xavier, R.J.; van der Meer, J.W.; van Crevel, R.; Netea, M.G.
	2011	Microalbuminuria is not a valuable marker for relapse in Crohn's disease	Horjus, C.S.; Oijen, M.G.H. van; Davids, A.H.; Naber, A.H.J.; Jong, D.J. de
	2011	High prevalence of fatigue in inflammatory bowel disease: A case control study	Romkens, T.E.H.; Vugt-van Pinxteren, M.W. van; Nagengast, F.M.; Oijen, M.G.H. van; Jong, D.J. de
	2011	Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study	Vos, A.C.; Bakkal, N.; Minnee, R.C.; Casparie, M.K.; Jong, D.J. de; Dijkstra, G.; Stokkers, P.; Bodegraven, A.A. van; Pierik, M.; Woude, C.J. van der; Oldenburg, B.; Hommes, D.W.
	2011	HNF4alpha and CDH1 are associated with ulcerative colitis in a Dutch cohort	Sommeren, S. van; Visschedijk, M.C.; Festen, E.A.; Jong, D.J. de; Ponsioen, C.Y.; Wijmenga, C.; Weersma, R.K.
	2011	Malignant transformation of perianal and enterocutaneous fistulas is rare: results of 17 years of follow-up from The Netherlands	Baars, J.E.; Kuipers, E.J.; Dijkstra, G.; Hommes, D.W.; Jong, D.J. de; Stokkers, P.C.; Oldenburg, B.; Pierik, M.; Wahab, P.J.; Bodegraven, A.A. van; Woude, C.J. van der
	2011	Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease.	Rivas, M.A.; Beaudoin, M.; Gardet, A.; Stevens, C.; Sharma, Y.; Zhang, C.K.; Boucher, G.; Ripke, S.; Ellinghaus, D.; Burtt, N.; Fennell, T.; Kirby, A.; Latiano, A.; Goyette, P.; Green, T.; Halfvarson, J.; Haritunians, T.; Korn, J.M.; Kuruvilla, F.; Lagace, C.; Neale, B.; Lo, K.S.; Schumm, P.; Torkvist, L.; Dubinsky, M.C.; Brant, S.R.; Silverberg, M.S.; Duerr, R.H.; Altshuler, D.; Gabriel, S.; Lettre, G.; Franke, A.; D'Amato, M.; McGovern, D.P.; Cho, J.H.; Rioux, J.D.; Xavier, R.J.; Daly, M.J.; Jong, D.J. de
	2011	Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease	Nijmeijer, R.M.; Gadaleta, R.M.; Mil, S.W. van; Bodegraven, A.A. van; Crusius, J.B.; Dijkstra, G.; Hommes, D.W.; Jong, D.J. de; Stokkers, P.C.; Verspaget, H.W.; Weersma, R.K.; Woude, C.J. van der; Stapelbroek, J.M.; Schipper, M.E.; Wijmenga, C.; Erpecum, K.J. van; Oldenburg, B.
	2011	Misclassification of dysplasia in patients with inflammatory bowel disease: consequences for progression rates to advanced neoplasia	Schaik, F.D. van; Kate, F.J. ten; Offerhaus, G.J.; Schipper, M.E.; Vleggaar, F.P.; Woude, C.J. van der; Stokkers, P.C.; Jong, D.J. de; Hommes, D.W.; Bodegraven, A.A. van; Siersema, P.D.; Oldenburg, B.
	2011	Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2	Plantinga, T.S.; Crisan, T.O.; Oosting, M.; Veerdonk, F.L. van de; Jong, D.J. de; Philpott, D.J.; Meer, J.W. van der; Girardin, S.E.; Joosten, L.A.B.; Netea, M.G.
	2011	Differential Toll-like receptor recognition and induction of cytokine profile by Bifidobacterium breve and Lactobacillus strains of probiotics	Plantinga, T.S.; Maren, W.W.C. van; Bergenhenegouwen, J. van; Hameetman, M.; Nierkens, S.; Jacobs, C.W.; Jong, D.J. de; Joosten, L.A.B.; Land, B. van't; Garssen, J.; Adema, G.J.; Netea, M.G.
	2011	Effect of childbirth on the course of Crohn's disease; results from a retrospective cohort study in the Netherlands	Smink, M.; Lotgering, F.K.; Albers, L.; Jong, D.J. de
	2011	Appropriate infliximab infusion dosage and monitoring: results of a panel meeting of rheumatologists, dermatologists and gastroenterologists	Vries, H.S. de; Oijen, M.G.H. van; Driessen, R.J.B.; Jong, E.M. de; Creemers, M.C.W.; Kievit, W.; Jong, D.J. de
	2010	Recognition of Borrelia burgdorferi by NOD2 is central for the induction of an inflammatory reaction.	Oosting, M.; Berende, A.; Sturm, P.D.J.; Hofstede, H.J.M. ter; Jong, D.J. de; Kanneganti, T.D.; Meer, J.W.M. van der; Kullberg, B.J.; Netea, M.G.; Joosten, L.A.B.
	2010	Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk.	Festen, E.A.; Stokkers, P.C.; Diemen, C.C. van; Bodegraven, A.A. van; Boezen, H.M.; Crusius, B.J.; Hommes, D.W.; Woude, C.J. van der; Balschun, T.; Verspaget, H.W.; Schreiber, S.; Jong, D.J. de; Franke, A.; Dijkstra, G.; Wijmenga, C.; Weersma, R.K.
	2010	Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohn's disease.	Woude, C.J. van der; Stokkers, P.; Bodegraven, A.A. van; Assche, G. Van; Hebzda, Z.; Paradowski, L.; D'Haens, G.; Ghosh, S.; Feagan, B.; Rutgeerts, P.; Dijkstra, G.; Jong, D.J. de; Oldenburg, B.; Farhan, M.; Richard, T.; Dean, Y.; Hommes, D.W.
	2010	Analysis of SNPs with an effect on gene expression identifies UBE2L3 and BCL3 as potential new risk genes for Crohn's disease.	Fransen, K.; Visschedijk, M.C.; Sommeren, S. van; Fu, J.Y.; Franke, L.; Festen, E.A.; Stokkers, P.C.; Bodegraven, A.A. van; Crusius, J.B.; Hommes, D.W.; Zanen, P.; Jong, D.J. de; Wijmenga, C.; Diemen, C.C. van; Weersma, R.K.
	2010	Richtlijn ‘Diagnostiek en behandeling van inflammatoire darmziekten bij volwassenen’. I. Diagnostiek en behandeling	Bodegraven, A.A. van; Everdingen, J.J. van; Dijkstra, G.; Jong, D.J. de; Oldenburg, B.; Hommes, D.W.
	2010	The functional -765G-->C polymorphism of the COX-2 gene may reduce the risk of developing Crohn's disease	Vries, H.S. de; Morsche, R.H.M. te; Oijen, M.G.H. van; Nagtegaal, I.D.; Peters, W.H.M.; Jong, D.J. de
	2010	Genome-wide association identifies multiple ulcerative colitis susceptibility loci.	McGovern, D.P.; Gardet, A.; Torkvist, L.; Goyette, P.; Essers, J.; Taylor, K.D.; Neale, B.M.; Ong, R.T.; Lagace, C.; Li, C.; Green, T.; Stevens, C.R.; Beauchamp, C.; Fleshner, P.R.; Carlson, M.; D'Amato, M.; Halfvarson, J.; Hibberd, M.L.; Lordal, M.; Padyukov, L.; Andriulli, A.; Colombo, E.; Latiano, A.; Palmieri, O.; Bernard, E.J.; Deslandres, C.; Hommes, D.W.; Jong, D.J. de; Stokkers, P.C.; Weersma, R.K.; Sharma, Y.; Silverberg, M.S.; Cho, J.H.; Wu, J.; Roeder, K.; Brant, S.R.; Schumm, L.P.; Duerr, R.H.; Dubinsky, M.C.; Glazer, N.L.; Haritunians, T.; Ippoliti, A.; Melmed, G.Y.; Siscovick, D.S.; Vasiliauskas, E.A.; Targan, S.R.; Annese, V.; Wijmenga, C.; Pettersson, S.; Rotter, J.I.; Xavier, R.J.; Daly, M.J.; Rioux, J.D.; Seielstad, M.
	2009	Safety of infliximab in inflammatory bowel disease needs to be debated.	Vries, H.S. de; Oijen, M.G.H. van; Jong, D.J. de
	2009	Veel vroeg optredend colorectaal carcinoom bij patiënten met inflammatoire darmziekte.	Lutgens, M.W.; Vleggaar, F.P.; Schipper, M.E.; Stokkers, P.C.; Woude, C.J. van der; Hommes, D.W.; Jong, D.J. de; Dijkstra, G.; Bodegraven, A.A. van; Oldenburg, B.; Samsom, M.
	2009	Monitoring vital signs during infusion with infliximab does neither indicate nor predict development of acute infusion reactions.	Vries, H.S. de; Oijen, M.G.H. van; Hoven-van Loo, K.E. van; Jong, D.J. de
	2009	Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease.	Lutgens, M.W.; Oldenburg, B.; Siersema, P.D.; Bodegraven, A.A. van; Dijkstra, G.; Hommes, D.W.; Jong, D.J. de; Stokkers, P.C.; Woude, C.J. van der; Vleggaar, F.P.
	2009	Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis.	Festen, E.A.; Goyette, P.; Scott, R.; Annese, V.; Zhernakova, A.; Lian, J.; Lefebvre, C.; Brant, S.R.; Cho, J.H.; Silverberg, M.S.; Taylor, K.D.; Jong, D.J. de; Stokkers, P.C.; Mcgovern, D.; Palmieri, O.; Achkar, J.P.; Xavier, R.J.; Daly, M.J.; Duerr, R.H.; Wijmenga, C.; Weersma, R.K.; Rioux, J.D.
	2009	High-dose Ara-C and beam with autograft rescue in R-CHOP responsive mantle cell lymphoma patients.	Veer, M.B. van 't; Jong, D.J. de; MacKenzie, M.A.; Kluin-Nelemans, H.C.; Oers, M.H. van; Zijlstra, J.; Hagenbeek, A.; Putten, W.L. van
	2009	Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium).	Jong, D.J. de; Xie, W.; Rosenwald, A.; Chhanabhai, M.; Gaulard, P.; Klapper, W.; Lee, A.; Sander, B.; Thorns, C.; Campo, E.; Molina, T.; Hagenbeek, A.; Horning, S.; Lister, A.; Raemaekers, J.M.M.; Salles, G.; Gascoyne, R.D.; Weller, E.
	2009	Caspase-12 and the inflammatory response to Yersinia pestis.	Ferwerda, B.; McCall, M.B.B.; Vries, M.C. de; Hopman, J.C.W.; Maiga, B.; Dolo, A.; Doumbo, O.; Daou, M.; Jong, D.J. de; Joosten, L.A.B.; Tissingh, R.A.; Reubsaet, F.A.; Sauerwein, R.W.; Meer, J.W.M. van der; Ven, A.J.A.M. van der; Netea, M.G.
	2009	Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols.	Jong, D.J. de; Koster, A.; Hagenbeek, A.; Raemaekers, J.M.M.; Veldhuizen, D.; Heisterkamp, S.; Boer, J.P. de; Glabbeke, M. van
	2009	More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis.	Claessen, M.M.; Lutgens, M.W.; Buuren, H.R. van; Oldenburg, B.; Stokkers, P.C.; Woude, C.J. van der; Hommes, D.W.; Jong, D.J. de; Dijkstra, G.; Bodegraven, A.A. van; Siersema, P.D.; Vleggaar, F.P.
	2009	Colectomy in patients with acute colitis: a systematic review.	Teeuwen, P.H.; Stommel, M.W.; Bremers, A.J.A.; Wilt, G.J. van der; Jong, D.J. de; Bleichrodt, R.P.
	2009	Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.	Weersma, R.K.; Stokkers, P.C.; Bodegraven, A.A. van; Hogezand, R.A. van; Verspaget, H.W.; Jong, D.J. de; Woude, C.J. van der; Oldenburg, B.; Linskens, R.K.; Festen, E.A.; Steege, G. van der; Hommes, D.W.; Crusius, J.B.; Wijmenga, C.; Nolte, I.M.; Dijkstra, G.
	2009	Genetic association analysis of the functional c.714T>G polymorphism and mucosal expression of dectin-1 in inflammatory bowel disease.	Vries, H.S. de; Plantinga, T.S.; Krieken, J.H.J.M. van; Stienstra, R.; Bodegraven, A.A. van; Festen, E.A.; Weersma, R.K.; Crusius, J.B.; Linskens, R.K.; Joosten, L.A.B.; Netea, M.G.; Jong, D.J. de
	2008	[Current options for percutaneous endoscopic access to the digestive tract]	Romkens, T.E.H.; Jong, D.J. de; Kristinsson, J.O.; Wanten, G.J.A.
	2008	NOD2 engagement induces proinflammatory cytokine production, but not apoptosis, in leukocytes isolated from patients with Crohn's disease.	Bodar, E.; Netea, M.G.; Jong, D.J. de; Kullberg, B.J.; Joosten, L.A.B.; Meer, J.W.M. van der
	2008	Crohn's disease patients homozygous for the 3020insC NOD2 mutation have a defective NOD2/TLR4 cross-tolerance to intestinal stimuli.	Kullberg, B.J.; Ferwerda, G.; Jong, D.J. de; Drenth, J.P.H.; Joosten, L.A.B.; Meer, J.W.M. van der; Netea, M.G.
	2008	No association of the CARD8 (TUCAN) c.30T>A (p.C10X) variant with Crohn's disease: a study in 3 independent European cohorts.	Buning, C.; Schmidt, H.H.; Molnar, T.; Drenth, J.P.H.; Fiedler, T.; Gentz, E.; Todorov, T.; Baumgart, D.C.; Sturm, A.; Nagy, F.; Lonovics, J.; Jong, D.J. de; Landt, O.; Kage, A.; Nickel, R.; Buttner, J.; Lochs, H.; Witt, H.
	2008	High frequency of early colorectal cancer in inflammatory bowel disease.	Lutgens, M.W.; Vleggaar, F.P.; Schipper, M.E.; Stokkers, P.C.; Woude, C.J. van der; Hommes, D.W.; Jong, D.J. de; Dijkstra, G.; Bodegraven, A.A; Oldenburg, B.; Samsom, M.
	2008	Serious events with infliximab in patients with inflammatory bowel disease: a 9-year cohort study in the Netherlands.	Vries, H.S. de; Oijen, M.G.H. van; Jong, D.J. de
	2008	Laparoscopic ileocolic resection versus infliximab treatment of distal ileitis in Crohn's disease : a randomized multicenter trial (LIR!C-trial)	Eshuis, E.J.H.M.; Bemelman, W.A.; Bodegraven, A.A.; Sprangers, M.A.G.; Bossuyt, P.M.; Wit, A.W. van Milligen de; Crolla, R.M.; Cahen, D.L.; Oostenbrug, L.E.; Sosef, M.N.; Voorburg, A.M.; Davids, P.H.; Woude, C.J. van der; Lange, J. de; Mallant, R.C.; Boom, M.J.; Lieverse, R.J.; Zaag, E.S. van der; Houben, M.H.; Vecht, J.; Pierik, R.E.; Ditzhuijsen, T.J. van; Prins, H.A.; Marsman, W.A.; Stockmann, H.B.; Brink, M.; Consten, E.C.; Werf, S.D. van der; Marinelli, A.W.; Jansen, J.M.; Gerhards, M.F.; Bolwerk, C.J.; Stassen, L.P.; Spanier, B.W.; Bilgen, E.J.; Berkel, A.M. van; Cense, H.A.; Heukelem, H.A. van; Laar, A. van t; Slot, W.B.; Eijsbouts, Q.A.; Ooteghem, N.A. van; Wagensveld, B.; Brande, J.M. van den; Geloven, A.A. van; Bruin, K.F.; Maring, J.K.; Oldenburg, B.; Hillegersberg, R. van; Jong, D.J. de; Bleichrodt, R.; Peet, D.L. van der; Dekkers, P.E.; Goei, T.H.; Stokkers, P.C.
	2007	A study in three European IBD cohorts confirms that the ATG16L1 c.898A>G (p.Thr300Ala) variant is a susceptibility factor for Crohn's disease	Buning, C.; Schmidt, H.; Durmus, T.; Molnar, T.; Jong, D.J. de; Drenth, J.P.H.; Fiedler, T.; Gentz, E.; Todorov, T.; Haas, V.; Buhner, S.; Sturm, A.W.; Baumgart, D.C.; Nagy, F.; Lonovics, J.; Landt, O.; Kage, A.; Buning, H.; Nickel, R.; Buttner, J.; Lochs, H.; Witt, H.
	2007	Potential role of pharmacogenetics in anti-TNF treatment of rheumatoid arthritis and Crohn's disease.	Kooloos, W.M.; Jong, D.J. de; Huizinga, T.W.J.; Guchelaar, H.J.
	2007	[Tracing colorectal carcinoma in patients with inflammatory bowel disease]	Jong, D.J. de; Nagengast, F.M.
	2007	Maintenance treatment with budesonide 6 mg versus 9 mg once daily in patients with Crohn's disease in remission.	Jong, D.J. de; Bac, D.J.; Tan, G.; Boer, S.Y. de; Grabowsky, I.L.; Jansen, J.B.M.J.; Greinwald, R.; Naber, A.H.J.
	2007	Extended thiopurine metabolite assessment during 6-thioguanine therapy for immunomodulation in Crohn's disease.	Boer, N.K. de; Derijks, L.J.; Keizer-Garritsen, J.J.; Lambooy, L.H.J.; Ruitenbeek, W.; Hooymans, P.M.; Bodegraven, A.A; Jong, D.J. de
	2007	Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2.	Ferwerda, G.; Kullberg, B.J.; Jong, D.J. de; Girardin, S.E.; Langenberg, D.M.; Crevel, R. van; Ottenhoff, T.H.M.; Meer, J.W.M. van der; Netea, M.G.
	2007	Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy.	Lin, E.N.J.T. van; Kristinsson, J.O.; Philippens, M.E.P.; Jong, D.J. de; Vight, L.P. van der; Kaanders, J.H.A.M.; Leer, J.W.H.; Visser, A.G.
	2007	Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis.	Buning, C.; Schmidt, H.H.; Molnar, T.; Jong, D.J. de; Fiedler, T.; Buhner, S.; Sturm, A.; Baumgart, D.C.; Nagy, F.; Lonovics, J.; Drenth, J.P.H.; Landt, O.; Nickel, R.; Buttner, J.; Lochs, H.; Witt, H.
	2006	Guidelines for treatment with infliximab for Crohn's disease.	Hommes, D.W.; Oldenburg, B.; Bodegraven, A.A; Hogezand, R.A. van; Jong, D.J. de; Romberg-Camps, M.; Woude, J. van der; Dijkstra, G.

1 2 next